QUBT Stock Analysis: Quantum Computing | NASDAQ
Computer Hardware | NASDAQ, USA | Market Cap: 2.041m USD | 12M Return: -52.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 158M
Qual. Beats: 0
Rev. Trend: 67.2%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Quantum Computing Inc. (NASDAQ: QUBT) is a U.S.-based integrated photonics company that supplies quantum machines and related optical components to commercial and government customers. Its core technology revolves around thin-film lithium niobate (TFLN) chips, which are used to build electro-optical modulators, frequency-conversion devices, and micro-ring resonator cavities. Integrated photonics-similar to silicon photonics-aims to consolidate multiple light-based functions onto a single chip, offering potential advantages in speed, size, and energy efficiency over traditional electronic components.
In addition to component-level products, QUBT is developing an Entropy Quantum Computer (EQC) intended for complex optimization problems, and markets several photonic-based systems: Emucore and Neurawave reservoir-computing machines for neural network applications, LiDAR sensors for imaging through adverse conditions, a quantum photonic vibrometer for remote sensing, and quantum network and authentication products. The company was originally founded in 2001 as Innovative Beverage Group Holdings before pivoting to its current photonics focus and is headquartered in Hoboken, New Jersey.
- Government and defense contracts accelerate revenue growth
- Thin-film lithium niobate chip production scales commercially
- Competition intensifies from IBM and Google in quantum hardware
- Capital raises dilute shares amid ongoing EQC development losses
| Net Income: -39.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.03 > 0.02 and ΔFCF/TA 6.88 > 1.0 |
| NWC/Revenue: 22.8k% < 20% (prev 42.5k%; Δ -19.6k% < -1%) |
| CFO/TA -0.02 > 3% & CFO -35.3m > Net Income -39.7m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 66.67 > 1.5 & < 3 |
| Outstanding Shares: last quarter (162.4m) vs 12m ago 6.17% < -2% |
| Gross Margin: -15.39% > 18% (prev 29.61%; Δ -45.00% > 0.5%) |
| Asset Turnover: 0.47% > 50% (prev 0.16%; Δ 0.31% > 0%) |
| Interest Coverage Ratio: -137.2 > 6 (EBIT TTM -39.5m / Interest Expense TTM 288k) |
| A: 0.61 (Total Current Assets 1.01b - Total Current Liabilities 15.1m) / Total Assets 1.62b |
| B: -0.14 (Retained Earnings -223.2m / Total Assets 1.62b) |
| C: -0.04 (EBIT TTM -39.5m / Avg Total Assets 931.5m) |
| D: 68.40 (Book Value of Equity 1.60b / Total Liabilities 23.4m) |
| Altman-Z'' = 75.10 = AAA |
| DSRI: 3.0 (Receivables 9.63m/20.0k, Revenue 4.33m/385k) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 1.39 (AQ_t 0.37 / AQ_t-1 0.26) |
| SGI: 11.26 (Revenue 4.33m / 385k) |
| TATA: -0.00 (NI -39.7m - CFO -35.3m) / TA 1.62b) |
| Beneish M = 6.21 (Cap -4..+1) = D |
As of July 07, 2026, the stock is trading at USD 9.37 with a total of 8,558,104 shares traded. Over the past week, the price has changed by +2.07%, over one month by -10.33%, over three months by +36.59% and over the past year by -52.87%.
Current recommended Stop Loss: 6.70 (which is 28.5% or 2.8 ATR below the current price).
Quantum Computing has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy QUBT.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 18.3 | 95.6% |
P/S = 470.9487
P/B = 1.3316
Revenue TTM = 4.33m USD
EBIT TTM = -39.5m USD
EBITDA TTM = -33.3m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 3.68m USD (from shortLongTermDebtTotal, last quarter) (leases 3.68m already included)
Net Debt = -982.4m USD (calculated: Debt 3.68m - CCE 986.1m)
Enterprise Value = 1.06b USD (2.04b + Debt 3.68m - CCE 986.1m)
Interest Coverage Ratio = -137.2 (Ebit TTM -39.5m / Interest Expense TTM 288k)
EV/FCF = -25.17x (Enterprise Value 1.06b / FCF TTM -42.1m)
FCF Yield = -3.97% (FCF TTM -42.1m / Enterprise Value 1.06b)
FCF Margin = -970.6% (FCF TTM -42.1m / Revenue TTM 4.33m)
Net Margin = -916.2% (Net Income TTM -39.7m / Revenue TTM 4.33m)
Gross Margin = -15.39% ((Revenue TTM 4.33m - Cost of Revenue TTM 5.00m) / Revenue TTM)
Gross Margin QoQ = -19.53% (prev -49.49%)
Tobins Q-Ratio = 0.65 (Enterprise Value 1.06b / Total Assets 1.62b)
Interest Expense / Debt = 7.83% (Interest Expense 288k / Debt 3.68m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -31.2m (EBIT -39.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 66.67 (Total Current Assets 1.01b / Total Current Liabilities 15.1m)
Debt / Equity = 0.00 (Debt 3.68m / totalStockholderEquity, last quarter 1.60b)
Debt / EBITDA = 29.47 (negative EBITDA) (Net Debt -982.4m / EBITDA -33.3m)
Debt / FCF = 23.36 (negative FCF - burning cash) (Net Debt -982.4m / FCF TTM -42.1m)
Total Stockholder Equity = 1.12b (last 4 quarters mean from totalStockholderEquity)
RoA = -4.26% (Net Income -39.7m / Total Assets 1.62b)
RoE = -3.55% (Net Income TTM -39.7m / Total Stockholder Equity 1.12b)
RoCE = -2.46% (EBIT -39.5m / Capital Employed (Total Assets 1.62b - Current Liab 15.1m))
RoIC = -1.95% (negative operating profit) (NOPAT -31.2m / Invested Capital 1.61b)
WACC = 4.41% (E(2.04b)/V(2.04b) * Re(4.41%) + D(3.68m)/V(2.04b) * Rd(7.83%) * (1-Tc(0.21)))
Discount Rate = 4.41% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 73.33 | Cagr: 38.99%
[DCF] Fair Price = unknown (Cash Flow -42.1m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.02 | # QB: 0
Revenue Correlation: 67.20 | Revenue CAGR: 76.01% | SUE: 2.81 | # QB: 1
EPS current Quarter (2026-06-30): EPS=-0.05 | Chg30d=-14.13% | Revisions=+0% | Analysts=3
EPS next Quarter (2026-09-30): EPS=-0.08 | Chg30d=-23.08% | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=-0.33 | Chg30d=-67.77% | Revisions=-25% | GrowthEPS=-1.8% | GrowthRev=+5946.3%
EPS next Year (2027-12-31): EPS=-0.38 | Chg30d=-75.36% | Revisions=+25% | GrowthEPS=-15.2% | GrowthRev=+58.9%
[Analyst] Revisions Ratio: +17% (up=2, down=1)